Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Payables (2016 - 2025)

Cross Country Healthcare's Payables history spans 16 years, with the latest figure at $46.0 million for Q4 2025.

  • For Q4 2025, Payables fell 29.12% year-over-year to $46.0 million; the TTM value through Dec 2025 reached $46.0 million, down 29.12%, while the annual FY2025 figure was $46.0 million, 29.12% down from the prior year.
  • Payables reached $46.0 million in Q4 2025 per CCRN's latest filing, up from $42.3 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $193.0 million in Q4 2022 to a low of $42.3 million in Q3 2025.
  • Average Payables over 5 years is $100.4 million, with a median of $71.0 million recorded in 2021.
  • Peak YoY movement for Payables: surged 210.37% in 2022, then crashed 61.04% in 2024.
  • A 5-year view of Payables shows it stood at $109.8 million in 2021, then soared by 75.85% to $193.0 million in 2022, then crashed by 51.9% to $92.8 million in 2023, then tumbled by 30.03% to $64.9 million in 2024, then dropped by 29.12% to $46.0 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Payables are $46.0 million (Q4 2025), $42.3 million (Q3 2025), and $49.0 million (Q2 2025).